Scott Fidel Analyst PerformanceManaging Director / Senior Research Analyst at The Goldman Sachs GroupScott Fidel is a stock analyst at The Goldman Sachs Group focused in the medical sector, covering 18 publicly traded companies. Over the past year, Scott Fidel has issued 39 stock ratings, including buy, hold, and sell recommendations. While full access to Scott Fidel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Scott Fidel's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings91 Last 11 YearsBuy Recommendations54.95% 50 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution91RatingsDistribution of strong buy, buy, hold, and sell ratings by Scott Fidel.RatingPercentageCount Strong Buy0.0%0 ratings Buy54.9%50 ratings Hold36.3%33 ratings Sell8.8%8 ratingsOut of 91 total stock ratings issued by Scott Fidel at The Goldman Sachs Group, the majority (54.9%) have been Buy recommendations, followed by 36.3% Hold and 8.8% Sell.Best & Worst CallsBest Call000.0%CNCOct 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ARDTApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE66.7% of companies on NYSE12 companiesNASDAQ33.3% of companies on NASDAQ6 companiesScott Fidel, an analyst at The Goldman Sachs Group, currently covers 18 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical17 companies94.4%Finance1 company5.6%Scott Fidel of The Goldman Sachs Group specializes in stock coverage within the Medical sector, with additional focus on Finance companies.Coverage IndustriesIndustryPercentageMED - HMO5 companies27.8%MED - OUTP/HM CRE4 companies22.2%MEDICAL SERVICES4 companies22.2%MED - HOSPITALS3 companies16.7%INS - MULTI LINE1 company5.6%MED - NURSING HMS1 company5.6% Scott Fidel's Ratings History at The Goldman Sachs Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAVAHAveanna Healthcare5/15/2026Upgrade$7.44$11.00Overweight$0.0000.00% ROIADUSAddus HomeCare2/25/2026Lower Price Target$104.50$135.00Overweight$0.0000.00% ROIHUMHumana2/13/2026Lower Price Target$183.92$158.00Sell$0.0000.00% ROICVSCVS Health2/12/2026Boost Price Target$78.61$97.00Buy$0.0000.00% ROIMOHMolina Healthcare2/11/2026Lower Price Target$122.66$124.00Neutral$0.0000.00% ROIHCAHCA Healthcare1/28/2026Boost Price Target$486.09$558.00Buy$0.0000.00% ROICVSCVS Health12/10/2025Boost Price Target$78.65$95.00Buy$0.0000.00% ROIHUMHumana11/24/2025Lower Price Target$233.79$215.00Sell$0.0000.00% ROIARDTArdent Health11/14/2025Lower Price Target$9.29$17.00Overweight$0.0000.00% ROICICigna Group11/4/2025Lower Price Target$259.76$330.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ALHCAlignment Healthcare11/3/2025Reiterated Rating$16.86$22.00Buy$0.0000.00% ROICNCCentene10/30/2025Reiterated Rating$37.44$38.00Sell$0.0000.00% ROIHCAHCA Healthcare10/27/2025Boost Price Target$453.77$520.00Buy$0.0000.00% ROIMOHMolina Healthcare10/24/2025Lower Price Target$164.82$167.00Neutral$0.0000.00% ROIARDTArdent Health10/14/2025Initiated Coverage$14.10$19.00Neutral$0.0000.00% ROIUHSUniversal Health Services10/14/2025Initiated Coverage$197.74$219.00Neutral$0.0000.00% ROITHCTenet Healthcare10/14/2025Initiated Coverage$189.94$224.00Buy$0.0000.00% ROIHCAHCA Healthcare10/14/2025Initiated Coverage$410.71$470.00Buy$0.0000.00% ROIOSCROscar Health10/14/2025Initiated Coverage$20.36$17.00Neutral$0.0000.00% ROIMOHMolina Healthcare10/14/2025Initiated Coverage$194.44$207.00Neutral$0.0000.00% ROIELVElevance Health10/14/2025Initiated Coverage$351.43$343.00Neutral$0.0000.00% ROICNCCentene10/14/2025Initiated Coverage$36.38$33.00Sell$0.0000.00% ROIHUMHumana10/14/2025Initiated Coverage$270.84$235.00Sell$0.0000.00% ROIALHCAlignment Healthcare10/14/2025Initiated Coverage$17.31$21.00Buy$0.0000.00% ROICVSCVS Health10/14/2025Initiated Coverage$78.50$91.00Buy$0.0000.00% ROICICigna Group10/14/2025Initiated Coverage$295.60$370.00Buy$0.0000.00% ROIUNHUnitedHealth Group10/14/2025Initiated Coverage$358.80$406.00Buy$0.0000.00% ROIALHCAlignment Healthcare10/14/2025Initiated Coverage$17.26$21.00Buy$0.0000.00% ROIARDTArdent Health10/14/2025Initiated Coverage$14.30$19.00Neutral$0.0000.00% ROICICigna Group10/14/2025Initiated Coverage$301.91$370.00Buy$0.0000.00% ROICNCCentene10/14/2025Initiated Coverage$36.42$33.00Sell$0.0000.00% ROICVSCVS Health10/14/2025Initiated Coverage$79.67$91.00Buy$0.0000.00% ROIELVElevance Health10/14/2025Initiated Coverage$350.04$343.00Neutral$0.0000.00% ROIHCAHCA Healthcare10/14/2025Initiated Coverage$418.34$470.00Buy$0.0000.00% ROIMOHMolina Healthcare10/14/2025Initiated Coverage$194.55$207.00Neutral$0.0000.00% ROIOSCROscar Health10/14/2025Initiated Coverage$20.80$17.00Neutral$0.0000.00% ROITHCTenet Healthcare10/14/2025Initiated Coverage$195.94$224.00Buy$0.0000.00% ROIUHSUniversal Health Services10/14/2025Initiated Coverage$203.91$219.00Neutral$0.0000.00% ROIARDTArdent Health5/20/2025Reiterated Rating$15.09$21.00Overweight$0.0000.00% ROIARDTArdent Health4/1/2025Reiterated Rating$12.77$22.00Overweight$0.0000.00% ROIALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.See the 5 stocks to avoidARDTArdent Health3/26/2025Reiterated Rating$13.06$22.00Overweight$0.0000.00% ROIADUSAddus HomeCare3/12/2025Reiterated Rating$93.82$142.00Overweight$000.0000.00% ROIPNTGThe Pennant Group3/11/2025Reiterated Rating$23.06$38.00Overweight$00.0000.00% ROIAMEDAmedisys3/4/2025Reiterated Rating$92.00$101.00Equal Weight$0.0000.00% ROIUHSUniversal Health Services2/28/2025Boost Price Target$172.96$223.00Equal Weight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
